This study demonstrates improved implant stability with injectable platelet-rich fibrin in dental patients, highlighting potential benefits for osseointegration.
BACKGROUND Many methods are used to increase the osseointegration of dental implants. This study aimed to evaluate the effect of injectable platelet-rich fibrin (i-PRF) on the osseointegration of dental implants in 20 patients, as measured by resonance frequency analysis. MATERIAL AND METHODS The study included 20 patients, with each patient receiving 2 SLA implants. After preparing the 2 implant sockets in each patient, one socket was randomly selected and irrigated with i-PRF before implant placement, while the other socket was left untreated. Implant stability was evaluated using a frequency analysis device at a 3-month evaluation. RESULTS The initial implant stability quotient (ISQ) values of the implants in the the test group (i-PRF+) averaged 68.875±9.571, increasing to 74.237±8.283 after 3 months. In the control group (i-PRF-), the initial ISQ values averaged 73.275±7.699 and measured 73.662±8.089 after 3 months. The ISQ values of women in the i-PRF+ group were significantly higher than those of men (P=0.004), whereas no statistically significant difference was found between male and female patients in the i-PRF- group (P=0.399). No statistically significant difference was found in ISQ values based on bone density in either the test or control groups (test group, P=0.109; control group, P=0.430). CONCLUSIONS Implants treated with i-PRF demonstrated significantly higher stability values in resonance frequency evaluations compared to untreated implants. Additionally, while i-PRF application resulted in a significantly greater increase in stability in women than in men, bone density did not have an effect on stability.
No takes yet. Share an insight, caveat, or question.
Hasanzade et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: